companiesandmarkets.com

Return to Report | Print

ACADIA Pharmaceuticals Inc. -Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/acadia-pharmaceuticals-inc.-premium-company-profile-41331.asp

Report Summary

Introduction

ACADIA Pharmaceuticals is a clinical development stage biopharmaceutical company mainly focused on discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system (CNS) disorders utilizing its innovative R-SAT functional assay technology.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    ACADIA Pharmaceuticals has a pipeline of drug candidates including: Pimavanserin, as a co-therapy for schizophrenia and for the treatment of Parkinson's disease psychosis; ACP-104, for treatment of schizophrenia; and a neuropathic pain program in Phase II development in collaboration with Allergan.

    It derives 100% of its revenues from research and milestone payments under its collaboration agreements with strategic partners Allergan, Sepracor and The Stanley Medical Research Institute for the development of new drug candidates and therapeutics. During 2002-2006, it's total revenues increased at a CAGR of 7%, from $6 million to $8 million.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 9
    Locations and Subsidiaries 11
    Company Financials 12
    Stock Market Performance 12
    P&L 13
    Balance Sheet 16
    Cash Flow 16
    Business Segment Performance 17
    Products & Services 18
    Pipeline Products 18
    AC Forecast Product Sales 22
    Competitors and Strategic Business Relationships 24
    Top Competitors 24
    Key Suppliers 25
    Key Clients 25
    Shareholding Structure 26
    Strategy 27
    Company View 27
    Corporate Strategy 28
    SWOT Analysis 30
    Overview 30
    Strengths 31
    Weaknesses 32
    Opportunities 33
    Threats 34
    Value Chain Analysis 35
    Overview 35
    Discovery and Product Development 35
    Scorecard 37
    Overview 37
    Scorecard Analysis 38
    Key Employees 39
    List of Key Employees 39
    Key Employee Biographies 40
    Financial and Operational Overview 46
    Financial and Operational Overview 46
    Appendix 49
    Ask the analyst 49
    Datamonitor consulting 49
    Disclaimer 49


    TABLE OF FIGURES
    Figure 1: ACADIA - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
    Figure 2: ACADIA - Key Strategic Revenues, 2006-2010 ($ Mn) 23


    TABLE OF TABLES
    Table 1: ACADIA - Key Facts 6
    Table 2: ACADIA - Other Locations and Subsidiaries 11
    Table 3: ACADIA - Year-End Share Price and Market Capitalization, 2002-2006 ($) 12
    Table 4: ACADIA - Key Events Impacting Share Price Performance 12
    Table 5: ACADIA - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
    Table 6: ACADIA - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 15
    Table 7: ACADIA - Balance Sheet, 2002-2006 ($ Mn) 16
    Table 8: ACADIA - Cash Flow, 2002-2006 ($ Mn) 16
    Table 9: ACADIA - Revenue Breakdown, 2002-2006 ($ Mn) 17
    Table 10: ACADIA – In-house Pipeline Products 18
    Table 11: ACADIA – Collaboration Pipeline Products 20
    Table 12: ACADIA – Forecast Sales, 2006-2010 ($ Mn) 22
    Table 13: ACADIA – Top Competitors 25
    Table 14: ACADIA – Key Suppliers 25
    Table 15: ACADIA – Key Clients 25
    Table 16: ACADIA - Key Shareholders 26
    Table 17: ACADIA - SWOT Analysis Summary 30
    Table 18: ACADIA – Value Chain Analysis 35
    Table 19: ACADIA - Scorecard 37
    Table 20: ACADIA - Key Employees 39
    Table 21: ACADIA - Financial and Operational Overview 47